What's new

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised

May 7, 2025 - 15:57
 0
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Finlee, dabrafenib, Date of authorisation: 15/11/2023, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

Motor retail suppliers, tell us about your tech!

Next Article

The Cultured Collective brings in new chairperson to help fuel growth

Related Posts

Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 28, 2025  0

Human medicines European public assessment report (EPAR): Emend, aprepitant, Date of authorisation: 11/11/2003, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0

Business process description for scientific advice

Apr 22, 2025  0